Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
γδ T Cell Immunotherapy for Breast Cancer
NCT03183206Phase 2Completed
- Sponsor
- Fuda Cancer Hospital
- Start
- Jun 2017
- Primary completion
- Jun 2018
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of Vγ9Vδ2 T cells in breast cancer, sponsored by Fuda Cancer Hospital. Started Jun 2017; status: completed.
02
Drugs
Vγ9Vδ2 T cells
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03183206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03183206.